Startup profile for Layer Health: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Layer Health funding, valuation and investors

Boston clinical-AI software provider automating evidence-linked medical-record abstraction for hospital quality registries and related workflows.

Verified company research · funding, investors and latest developments

Keep track of Layer Health

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Strategic investor participation in Series A (not a new priced round)

Amount undisclosed · November 19, 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$25M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series a · Boston, Massachusetts, United States

Investors in latest funding

Other: Banner Health

Sources: latest funding · prnewswire.com Last verified: 2026-11-19

Overview

Layer Health, a Boston-based AI healthcare technology company founded by clinical AI researcher and CEO David Sontag and colleagues, extracts structured answers and traceable clinical evidence from longitudinal patient records.

Its clinical-registry platform supports hospital abstractors submitting information to national cardiovascular, surgical, oncology and stroke registries; related products serve clinical pathways and quality measurement.

An illustrative registry workflow: connect Epic or Cerner through the vendor-described FHIR-first integrations; baseline how many minutes manual abstractors spend per case; validate the model against the hospital's historical records; show source-linked AI suggestions inside the abstractor workflow; have qualified staff verify or override findings; track field-level accuracy, backlogs and time saved before considering greater automation.

The company lists both software for in-house teams and AI-assisted abstraction services. Its vendor marketing claims 50–60%+ time savings, 98%+ validated accuracy and deployment in under ten weeks; results vary by hospital, registry and field, and no independently audited universal claim is established. Pricing is enterprise quote-only; per-chart costs, contract commitments, patient-level error rates and profitability are not public.

Its November 19, 2026 company-issued wire release announced Banner Health's amount-undisclosed strategic participation in its Series A and the beginning of a multi-year registry deployment, not a newly reported $21M round. Layer's earlier company releases reported a $4M seed on November 14, 2023 and $21M Series A on March 27, 2025 led by Define Ventures.

Its announced partner relationships include White Plains, Johns Hopkins, Intermountain and Fairview, but case studies are selected company reports rather than independent proof of clinical outcome improvements.

Why Layer Health is interesting

On November 19, 2026, Banner Health disclosed a strategic investment in Layer Health as part of its Series A financing alongside a multi-year enterprise registry rollout. The investment amount was not disclosed and must not be added to Layer's separately announced $21M March 2025 Series A or $4M November 2023 seed. Banner's deployment is a commercially meaningful reference, not proof of a new $21M round.

Product & use cases

BUYER/JOURNEY (illustrative based on vendor documentation, not hands-on testing): (1) Hospital registry director chooses a program (for example stroke, cardiology or surgery) and supplies its data-access and governance requirements. (2) Layer connects to supported Epic/Cerner records using the vendor's FHIR-first integration, with appropriate patient permissions. (3) Historical chart cases establish an accuracy benchmark and abstractor minutes-per-case baseline. (4) AI recommends answers to each registry field, shows source excerpts in the actual patient chart and surfaces uncertainty for clinical staff to resolve. (5) Staff review and correct the suggested abstraction, retaining accountable human oversight and traceability for submissions. (6) Hospital checks quality/accuracy by field and workload across registries before broader rollout. Vendor also offers its own clinical abstraction service for transitional outsourcing. No self-serve prices are disclosed. Banner Health's Nov 19 announcement describes adoption across cardiovascular, surgery, oncology and stroke, but not validated post-implementation results.

  • Health-system quality team extracting clinical registry variables from Epic or Cerner records for cardiovascular, surgical, stroke or oncology submissions.
  • Clinical abstractor seeking chart-source evidence and human-reviewable AI-suggested fields rather than manually hunting across hundreds of notes.
  • Research teams preparing structured longitudinal cohorts, with additional privacy and validation requirements.

Key facts

  • Banner Health invested as a strategic hospital participant in Layer's existing Series A; announced November 19, 2026. Amount undisclosed; no justification to count a second $21M Series A.
  • Company previously announced $21M Series A March 27, 2025 led by Define Ventures, with GV, Flare Capital Partners and MultiCare Capital Partners; separate $4M seed November 14, 2023.
  • AI abstraction suggestions cite evidence from a patient's record; the hospital remains responsible for review, data quality and compliant registry submissions.
  • Vendor advertises 50–60%+ faster abstraction, 98%+ accuracy validated on customer data and less-than-ten-week go-live; neither universal efficacy nor causal patient benefit independently established.
  • Public pricing and Banner investment amount undisclosed. Clinical data governance, HIPAA obligations, model drift, bias, missed chart findings and implementation costs remain essential diligence.

Funding history (newest first)

Strategic investor participation in Series A (not a new priced round)

2026-11-19 Amount undisclosed
  • Banner Health (participant)

Source: Read source · prnewswire.com

Series A

2025-03-27 $21M

Source: Read source · layerhealth.com

Seed

2023-11-14 $4M

Source: Read source · layerhealth.com

Investors in our directory

Funds linked from Layer Health's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Unlike general-purpose clinical note summarizers, Layer targets evidence-linked field-by-field abstraction in regulated reporting workflows, adds customer-specific predeployment validation, registry rules and an option for service-led transitions. Vendor benchmark claims are selected results, not universal performance guarantees.

The ROI unit of account should be verified abstractor minutes per case multiplied by eligible case volume and burdened labor costs, net of vendor subscription, review, implementation and validation time; do not count theoretical recovered hours as booked revenue. For a buyer, compare each registry's field-level precision/recall, omissions, human override rates, documentation and audit evidence, integrations, security posture, data-retention arrangements and vendor-exit process. Banner's announced purchase and investment creates both a deployment example and a potential strategic relationship; it is not independent randomized evidence of improved outcomes. Business model appears enterprise software and optional abstraction services, but exact fees and margins are undisclosed.

  • Traditional manual clinical abstraction teams incumbent

    Human chart reviewers and external registry vendors perform established submissions but require substantial clinical labor and time. Comparing fully loaded minutes per case is more useful than comparing headline AI benchmark scores.

  • Q-Centrix direct

    Established clinical data abstraction and quality-management service alternative for hospitals; diligence should compare staffing model, integration and human review.

  • Carta Healthcare direct

    AI-assisted clinical data abstraction and registry optimization for health systems; compare covered registries, precision, validation and service structure.

  • Healthcare EHR-native reporting workflows alternative

    Epic/Cerner structured reports and existing quality tools may handle some coded fields but often lack reliable extraction of nuanced free-text notes.

Notable stories

Market / IPO context

Editorial / static context — not a live quote.

FAQs about Layer Health

Practical answers founders, operators, and investors typically search for.

Layer Health disclosed Banner Health's strategic participation in its Series A on November 19, 2026, without a dollar amount. The $21M Series A reported in March 2025 is a separate prior disclosed total and cannot be assigned to Banner.
It retrieves evidence from structured and unstructured patient charts, recommends answers to the data fields required by medical quality registries, and gives human abstractors source references to verify before submission.
No. Its public product promotes human review, customer-specific model validation and continuously monitored accuracy; benchmarked abstraction efficiency is not itself proof of improved clinical outcomes.
The vendor does not publish a universal per-chart or monthly fee. Enterprise purchasers request a demonstration and custom proposal, including any service and implementation charges.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.